Cancer

RSS

Cell Pathways and Glaxo Wellcome to study Aptosyn/Navelbine combination for NSCLC

July 21, 2000

Indena's new colchicine derivatives active against multidrug-resistant cancer cells

July 20, 2000

Arsenic trioxide receives third orphan drug designation from FDA

July 20, 2000

Photofrin approved in Sweden, Ireland and Italy

July 20, 2000

Onyx and Bayer begin clinical testing of Ras inhibitor

July 19, 2000

Synthesis, activity and use of new neovascularization inhibitors disclosed by Takeda

July 19, 2000

G-protein-targeted antisense oligonucleotides patented by Isis

July 19, 2000

Intranasal IM-862 effective and safe in patients with AIDS-related Kaposi's sarcoma

July 19, 2000

Tularik initiates phase II studies of T-64 for treatment of solid tumors

July 19, 2000

Novel nucleoside transport inhibitor NU-3108 deemed suitable for further development

July 18, 2000